作者：
Vincent H J,van der Velden [1]
;
Juan,Flores-Montero [2]
;
Martin,Perez-Andres [2]
;
Marta,Martin-Ayuso [3]
;
Oliver,Crespo [4]
;
Elena,Blanco [2]
;
Tomas,Kalina [5]
;
Jan,Philippé [6]
;
Carolien,Bonroy [6]
;
Maaike,de Bie [7]
;
Jeroen,Te Marvelde [7]
;
Cristina,Teodosio [2]
;
Alba,Corral Mateos [2]
;
Veronika,Kanderová [5]
;
Mirjam,van der Burg [7]
;
Dennis,Van Hoof [4]
;
Jacques J M,van Dongen [8]
;
Alberto,Orfao [2]
作者单位：
Laboratory for Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. Electronic address: v.h.j.vandervelden@erasmusmc.nl.
[1]
Cancer Research Centre (IBMCC, USAL-CSIC), Institute for Biomedical Research of Salamanca (IBSAL) and Department of Medicine and Cytometry Service (NUCLEUS Research Support Platform), University of Salamanca (USAL), Salamanca, Spain.
[2]
Cytognos SL, Salamanca, Spain.
[3]
BD Biosciences, San Jose, USA.
[4]
Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University (DPH/O), Prague, Czech Republic.
[5]
Department of Laboratory Medicine, University Hospital Ghent, Ghent, Belgium.
[6]
Laboratory for Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
[7]
Department of Immunohematology and Blood Transfusion (IHB), Leiden University Medical Center (LUMC), Leiden, The Netherlands.
[8]
DOI
10.1016/j.jim.2017.03.011
PMID
28341440
发布时间
2020-05-11
换一批
换一批
